13 October 2021 - Deborah Wilkes
Premium
Italian pharmaceutical company Alfasigma has appointed Francesco Balestrieri as chief executive officer with effect from 1 November 2021.
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.